🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Transpacific TAVR Registry

Recruitingn/aAges 19 Years - anyAllDuk-Woo Park, MD
NCT03826264 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This registry evaluates the long-term outcome of Transcatheter aortic valve replacement (TAVR) in real-world clinical practice.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * All patients undergoing TAVR * Informed consent
💊

What it tests

  • TAVR
📍

Where

7 sites
Stanford University
Stanford, United States
Northwestern Memorial Hospital
Chicago, United States
Second Affiliated Hospital of Zhejiang University
Hangzhou, China
Bucheon Sejong Hospital
Bucheon-si, South Korea
Chungnam National University Hospital
Daejeon, South Korea
Asan Medical Center
Seoul, South Korea
Seoul National University Hospital
Seoul, South Korea
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy